US OptionsDetailed Quotes
MEDP241220C620000
- 0.00
- 0.000.00%
15min DelayClose Nov 29 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest620.00Strike Price0.00Turnover0.00%IV82.02%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier19DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma70.96Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Medpace Stock Discussion
Sign in to post a comment
The market fell Tuesday after consumer and communications earnings came in mixed. Investors awaiting $Tesla (TSLA.US)$ earnings Wednesday to see if indexes keep growing to all-time highs.
After 4 pm ET, the $S&P 500 Index (.SPX.US)$ fell 0.05%, the $Dow Jones Industrial Average (.DJI.US)$ fell 0.02%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.17%.
MACRO
Senior Federal Reserve official Mary Daly said. Economic growth and the labor ma...
After 4 pm ET, the $S&P 500 Index (.SPX.US)$ fell 0.05%, the $Dow Jones Industrial Average (.DJI.US)$ fell 0.02%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.17%.
MACRO
Senior Federal Reserve official Mary Daly said. Economic growth and the labor ma...
39
6
Investors expect Medpace Holdings to outperform the market, hence its high P/E ratio. Strong future growth anticipation makes investors pay more for the stock, supporting the share price.
1
Medpace Holdings' robust conversion of profit to free cash flow is promising. Its underlying earnings potential may even surpass the statutory profit. Its earnings per share have seen a remarkable growth over the past three years.
1
Medpace Holdings' market sentiment remains steady, mirroring EPS growth. The stock's recent performance shows improvement, with a 90% shareholder return over the last year, surpassing the five-year TSR of 41% per year. The strong share price momentum suggests a closer look at the stock may be worthwhile.
Medpace's high P/E is backed by its forecast growth being higher than the wider market. Investors are quite confident in the company's future earnings and seem willing to pay more for the stock, suggesting a bullish outlook.
Insider selling at current price (US$274) is less worrying, but there were no purchases over the past year to boost confidence. A high level of insider ownership often implies interests of all shareholders are considered, though recent history of share sales triggers some hesitation.
Medpace's market sentiment appears constant over years, mirroring its EPS growth. The company's five-year total shareholder return of 38% per year impresses.
Here are the top gap ups and downs for the stocks with a market cap above $5 billion after the previous market closed (gaps range from large to small):
Gap Ups
1. $Medpace (MEDP.US)$ - up 8.3%
2. $Hubbell (HUBB.US)$ - up 7.3%
3. $Novartis AG (NVS.US)$ - up 2.6%
4. $Spotify Technology (SPOT.US)$ - up 1.9%
5. $ABB Ltd (ABB.US)$ - up 1.8%
6. $Centene (CNC.US)$ - up 1.5%
7. $Kimberly-Clark (KMB.US)$ - up 0.9%
8. $Nomura Holdings (NMR.US)$ ...
Gap Ups
1. $Medpace (MEDP.US)$ - up 8.3%
2. $Hubbell (HUBB.US)$ - up 7.3%
3. $Novartis AG (NVS.US)$ - up 2.6%
4. $Spotify Technology (SPOT.US)$ - up 1.9%
5. $ABB Ltd (ABB.US)$ - up 1.8%
6. $Centene (CNC.US)$ - up 1.5%
7. $Kimberly-Clark (KMB.US)$ - up 0.9%
8. $Nomura Holdings (NMR.US)$ ...
+16
6
Here are the top gap ups and downs for the stocks with a market cap above $5 billion after the previous market closed (gaps range from large to small):
Gap Ups
1. $Medpace (MEDP.US)$ - up 25.01%
2. $Logitech International (LOGI.US)$ - up 8.07%
3. $UBS Group (UBS.US)$ - up 5.36%
4. $SAP SE (SAP.US)$ - up 5.30%
5. $Charles River (CRL.US)$ - up 4.30%
6. $IQVIA Holdings (IQV.US)$ - up 3.77%
7. $U-Haul (UHAL.US)$ - up 2.80%
8. $Roblox (RBLX.US)$...
Gap Ups
1. $Medpace (MEDP.US)$ - up 25.01%
2. $Logitech International (LOGI.US)$ - up 8.07%
3. $UBS Group (UBS.US)$ - up 5.36%
4. $SAP SE (SAP.US)$ - up 5.30%
5. $Charles River (CRL.US)$ - up 4.30%
6. $IQVIA Holdings (IQV.US)$ - up 3.77%
7. $U-Haul (UHAL.US)$ - up 2.80%
8. $Roblox (RBLX.US)$...
+11
15
Follow for nightly watchlist ⭐️
$Applied Genetic (AGTC.US)$ $ALFI Inc (ALF.US)$ $Alibaba (BABA.US)$ $Femto Technologies (BCAN.US)$ $Discover Financial Services (DFS.US)$ $Logitech International (LOGI.US)$ $Medpace (MEDP.US)$ $3M (MMM.US)$ $Mullen Automotive (MULN.US)$ $Tricida (TCDA.US)$ $XPeng (XPEV.US)$ $Qualtrics International (XM.US)$
2
1
No comment yet
KietVo : Don’t let fake new hurting your investment
72436069 : NVDA and Avgo
104247826 :![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
103675326 : something wrong with the report on TI how would hitting $4.1x become 100% below $4.2x or $4.5x
affable Blobfish_403 : The strength of protecting the market during the election is weak.
View more comments...